Sign up to see all 5.
Sign up to see all 5.
No insider has filed a notice of proposed sale (Form 144) for Nuvectis Pharma, Inc. in the last 12 months.
| Holder | Shares | % of company | Change vs last qtr | 8 quarters | Held since | % of their book |
|---|---|---|---|---|---|---|
|
TC
Tang Capital Management LLC
|
1.6M | 5.26% | NEW | Q2 '26 | 1.3% | |
|
Shares held by quarter
Peak holding1.6M (Q2'26)
Change over 8 quarters+1.6M
Share of the company5.260%
|
||||||
|
B
BlackRock, Inc.
|
1.0M | 3.40% | +236.8K (+31.0%) | 2022 | 0.0% | |
|
Shares held by quarter
Peak holding1.0M (Q2'26)
Change over 8 quarters+951.7K
Share of the company3.400%
|
||||||
28 more super investors behind a free account
See every manager holding Nuvectis Pharma, Inc., how their position has changed, and how long they've held it.
Sign up free| Fund | Position value | Shares | % of company | % of the fund | As of |
|---|---|---|---|---|---|
|
VT
Vanguard Index Funds
|
$8.87M | 482.1K | 1.64% | 0.00% | June 30, 2026 |
|
IR
iShares Trust
|
$7.92M | 430.8K | 1.46% | 0.01% | June 30, 2026 |
23 more funds behind a free account
See every fund holding Nuvectis Pharma, Inc. and how much of the fund the position is.
Sign up free| Holder | Shares | % of company | Change vs last qtr | 8 quarters | Held since | % of their book |
|---|---|---|---|---|---|---|
|
BR
Bentsur Ron
Insider
|
3.7M | 12.52% | — | — |
— | — |
|
Insider holdings come from Form 3/4/5 filings, which are not quarterly.
Share of the company12.520%
|
||||||
|
MM
Mosseri Marlio Charles
Insider
|
3.3M | 11.19% | — | — |
— | — |
|
Insider holdings come from Form 3/4/5 filings, which are not quarterly.
Share of the company11.190%
|
||||||
7 more holders behind a free account
See every insider and 5%+ holder of Nuvectis Pharma, Inc..
Sign up freeLoading...